Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 09-2014 | 06-2014 | 05-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,665 | -6,574 | -4,553 | 0 | -2,968 |
| Depreciation Amortization | 1,334 | 825 | 495 | 0 | 695 |
| Other Working Capital | 1,770 | 850 | 182 | 0 | 2,305 |
| Other Operating Activity | 2,686 | 3,366 | 2,865 | 0 | -2,158 |
| Operating Cash Flow | $-1,874 | $-1,533 | $-1,012 | $0 | $-2,126 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -10 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 0 | 250 |
| Debt Repayment | -241 | -197 | -108 | 0 | -156 |
| Common Stock Issued | 2,128 | 1,730 | 1,520 | 0 | 1,340 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 64 |
| Financing Cash Flow | $1,888 | $1,533 | $1,413 | $0 | $1,498 |
| Beginning Cash Position | N/A | N/A | N/A | 0 | 638 |
| End Cash Position | 13 | N/A | 401 | 0 | N/A |
| Net Cash Flow | $13 | $N/A | $401 | $0 | $-638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,874 | -1,533 | -1,012 | 0 | -2,126 |
| Capital Expenditure | N/A | N/A | N/A | 0 | -10 |
| Free Cash Flow | -1,874 | -1,533 | -1,012 | 0 | -2,136 |